Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £23.14, which the company achieved on ...

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can ...

PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday, February 26, 2025. The company will make a recording of ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Hikma Pharmaceuticals (LON:HIK – Free Report) had its price objective lifted by Berenberg Bank from GBX 2,400 ($29.74) to GBX 2,560 ($31.73) in a research note published on Wednesday morning, ...

announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and Canada to Hikma Pharmaceuticals’ KLOXXADO ® (naloxone HCl) Nasal Spray, an 8 mg ...

Hikma recently received the Food and Drug Administration’s permission for a new generic, and the company also launched two new generic products. The FDA approved Hikma's first generic ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an agreement with the Abu Dhabi ...

Shares of Hikma Pharmaceuticals PLC HIK advanced 1.63% to £22.48 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...